The Virtual Press Room is a courtesy for corporate and institutional public relations professionals. Publication of material on this page does not constitute an endorsement by ASCO of any product or claim. For information about how to submit a press release to the Virtual Press Room, visit the For PR Professionals page.

2017 ASCO Annual Meeting

Astellas
Astellas Announces Record Number of Abstracts Highlighting Breadth and Depth of Oncology Portfolio Data to be Presented at 2017 ASCO Annual Meeting

Cancer Research UK
Drug Improves Survival of Patients With Rare Cancer by Almost a Quarter

Daiichi Sankyo
Daiichi Sankyo Cancer Enterprise Pipeline Data Showing Swift Progress in Precision Medicine for Breast Cancer to be Presented at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Flatiron Health
Flatiron Health Announces Collaborative Research to be Presented at ASCO’s 2017 Annual Meeting

Fred Hutchinson Cancer Research Center
Many Patients With Early-Stage Breast Cancer Receive Costly, Inappropriate Testing, Says Fred Hutch Study
Triple Immunotherapy for Rare Skin Cancer Shows Promise in Small, Early-Stage Trial, Fred Hutch

Melanoma Institute Australia
World First - Australian Researchers Pioneer Life-Extending Treatment for Advanced Melanoma Patients With Brain Tumours

PharmaMar
PharmaMar Announces New Data With its Compounds Yondelis® and Lurbinectedin During ASCO 2017

Rogers Sciences
Rogers Sciences, Inc. to Present at ASCO

Sarah Cannon Research Institute
Cancer Experts From Sarah Cannon Research Institute Present Latest in Cancer Research at American Society of Clinical Oncology's 2017 Annual Meeting

VAXIMM
VAXIMM Announces Data From Phase I Trial in Glioblastoma With Oral T-cell Immunotherapy VXM01 to be Presented at ASCO 2017 Annual Meeting